The board of directors of Lijun International Pharmaceutical (Holding) Co. Ltd. announced that a nomination committee comprising Mr. Wang Yibing as chairman, Mr. Leung Chong Shun and Mr. Chow Kwok Wai as members has been established by the Board with written terms of reference with effect from March 23, 2012. Mr. Wang, Mr. Leung and Mr. Chow are independent non-executive Directors. The primary duties of the Nomination Committee include but not limited to: review the structure, size and composition (including the skills, knowledge and experience) of the Board at least annually and make recommendations on any proposed changes to the Board to complement the Company's corporate strategy; identify individuals suitably qualified to become Board members and select or make recommendations to the Board on the selection of individuals nominated for directorships; assess the independence of independent non-executive Directors; and make recommendations to the Board on the appointment or re-appointment of Directors and succession planning for Directors, in particular the chairman and the chief executive officer.